Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 24 filingsยทUpdated 22 Aug 2026
Showing 10 of 24 filings.
22 Aug 20261 filing
OthersOutcome without intimation

M. K. Proteins appoints Aritika Garg as Additional Non-Executive Independent Director, subject to AGM approval

Appointments/Resignations

  • Ms. Aritika Garg appointed as Non-Executive Independent Director (Additional) effective 22 Aug 2026, five-year term, subject to AGM.
  • Profile: Chartered Accountant with 15+ years in accounting, finance, audit; independent director eligibility met.
  • Not related to any director and not debarred by SEBI.
Filed 15:43View Source
14 Aug 20262 filings
Company UpdateNewspaper Publication

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, we are enclosing herewith the copies of Newspaper publications in the Financial Express (English Edition) and Jansatta (Hindi ....

Filed 16:53View Source
Company UpdateCopy of Newspaper Publication

M K Proteins Limited has informed the Exchange about Copy of Newspaper publications in the Financial Express (English Edition) and Jansatta (Hindi Edition) regarding the Un-Audited Financial Results of the Company for the quarter ended June 30, 2026.

Filed 16:49View Source
13 Aug 20261 filing
Company UpdateResignation of Director

Independent Director Laxmi Mandal resigns from M. K. Proteins, effective 12 August 2026

Resignation details

  • Name and designation: Ms. Laxmi Mandal, Independent Director.
  • Effective date of resignation: 12 August 2026.
  • Reason for resignation: due to her other business obligations.
  • Director confirms no other material reasons beyond those stated.
  • Directorships/committee memberships held in listed entities: NIL.
Filed 12:00View Source
14 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Regulation 74(5) not applicable; entire holding in demat; no demat/remat requests.

Dematerialisation status

  • Regulation 74(5) not applicable; entire holding in demat; no demat/remat requests.
Filed 10:43View Source
1 Jun 20261 filing
Company UpdateNewspaper Publication

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting the copies of Newspaper publications in the Financial Express (English ....

Filed 11:21View Source
29 May 20261 filing
ResultFinancial Results

M. K. Proteins Ltd - 543919 - Audited Standalone Financial Results Of The Company For The Quarter And Year Ended 31St March, 2026

FY26 audited results

  • ๐Ÿ“Š Revenue from operations rose 43.0% YoY to โ‚น38,287.52 lakh.
  • ๐Ÿ“Š Total income increased 42.6% YoY to โ‚น38,313.46 lakh.
  • ๐Ÿ“Š PBT fell 18.0% YoY to โ‚น938.86 lakh.
  • ๐Ÿ“Š PAT declined 18.7% YoY to โ‚น682.90 lakh.
  • ๐Ÿ“Š Q4 FY26 revenue from operations was โ‚น14,594.06 lakh, up 63.0% YoY.
  • ๐Ÿ“Š Q4 FY26 PAT was โ‚น113.83 lakh, down 59.2% YoY.
  • ๐Ÿ“Š Basic and diluted EPS for FY26 were โ‚น0.18, versus โ‚น0.22 last year.
  • ๐Ÿ“Š Other comprehensive income was โ‚น0.54 lakh for FY26.
  • ๐Ÿ“Š Auditors issued an unmodified opinion on the standalone results.

Cost and balance sheet

  • ๐Ÿ“Š Cost of material consumed rose to โ‚น28,648.84 lakh in FY26.
  • ๐Ÿ“Š Purchase of stock-in-trade increased to โ‚น7,369.24 lakh in FY26.
  • ๐Ÿ“Š Finance costs rose to โ‚น185.20 lakh from โ‚น110.50 lakh.
  • ๐Ÿ“Š Inventories stood at โ‚น10,978.20 lakh at 31 March 2026.
  • ๐Ÿ“Š Trade receivables increased to โ‚น211.00 lakh from โ‚น140.33 lakh.
  • ๐Ÿ“Š Borrowings were โ‚น3,619.86 lakh at 31 March 2026.
  • ๐Ÿ“Š Cash and cash equivalents were โ‚น3.82 lakh at year-end.
  • ๐Ÿ“Š Equity increased to โ‚น7,630.02 lakh, supported by retained earnings.

Operations and cash flow

  • ๐Ÿ“Š Company operates a single business: manufacturing of vegetable refined oil.
  • ๐Ÿ“Š Capital work-in-progress was โ‚น709.77 lakh at 31 March 2026.
  • ๐Ÿงฑ FY26 capex on fixed assets and CWIP was โ‚น189.52 lakh.
  • ๐Ÿ“Š Operating cash generation was โ‚น799.06 lakh before taxes.
  • ๐Ÿ“Š Net cash flow for FY26 was โ‚น40.44 lakh.
  • ๐Ÿ“Š Short-term bank borrowings decreased by โ‚น202.97 lakh during FY26.

Borrowings and rating

  • ๐Ÿ“Š Outstanding borrowings were โ‚น36.19 crore at 31 March 2026.
  • ๐Ÿ“Š Borrowings declined from โ‚น37.75 crore at 31 March 2025.
  • ๐Ÿ“Š Incremental qualified borrowings were negative โ‚น1.56 crore in FY26.
  • ๐Ÿ“Š CRISIL assigned A rating to long-term and short-term bank facilities.

Board actions

  • ๐Ÿ“ Board approved audited standalone financial results for quarter and year ended 31 March 2026.
  • ๐Ÿ“ Board re-appointed M/s. K. K. Sinha & Associates as cost auditors for FY27.
  • ๐Ÿ“ Board re-appointed M/s. Jayant Bansal & Co. as internal auditors for FY27.
  • ๐Ÿ“ Related party transactions for half year ended 31 March 2026 were noted.

Audit

  • ๐Ÿ“Š Statutory auditors confirmed an unmodified opinion on the audited standalone financial results.

Business

  • ๐Ÿ“ M. K. Proteins manufactures vegetable refined oil.
  • ๐Ÿ“ Results are standalone for the quarter and year ended 31 March 2026.
Filed 17:17View Source
18 May 20261 filing
Board Meeting

M. K. Proteins Ltd - 543919 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For FY 2025-26 And Other Business Matters On Friday, 29.05.2026.

Meeting Details

  • Board meeting scheduled for Friday, 29 May 2026.

Key Agenda Items

  • Approve audited financial results for quarter and year ended 31 March 2026.
  • Re-appoint M/s. K. K. Sinha & Associates as cost auditors for FY 2026-27.
  • Re-appoint M/s. Jayant Bansal & Co. as internal auditor for FY 2026-27.

Other Notes

  • Trading window reopens 48 hours after declaration of the financial results.
Filed 11:20View Source
27 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for transactions in ....

Filed 10:43View Source
5 Feb 20261 filing
Board Meeting

M. K. Proteins Ltd - 543919 - Board Meeting Intimation for Approval Of The Un-Audited Financial Results Of The Company For The Quarter Ended 31St December, 2025

๐Ÿ—“๏ธ Meeting Details

  • Board meeting scheduled for 13 February 2026.

๐Ÿ“Š Key Agenda Items

  • Approval of unaudited financial results for quarter ended 31 December 2025.
Filed 16:30View Source
Showing 10 of 24 filings